In the pivotal SURPASS-2 trial, nausea occurred in 17-22% of patients on tirzepatide (varying by dose) compared to 18% on semaglutide 1 mg
The only situations where the scale may drop by 10 kg within 14 days include: Starting weight above 130 kg under a physician-supervised very-low-calorie diet (VLCD) The first 14 days of a gastric balloon program , combining physical restriction with a structured 8001,000 kcal diet Early initiation of GLP-1 medications in patients with significant water retention In all other cases, attempting to lose 10 kg in 14 days can lead to dangerous dehydration, electrolyte imbalance, and gallstone formation , and more than 90% of the weight lost is typically regained within 8 weeks
2018 updated European league against rheumatism evidence-based recommendations for the diagnosis of gout
Da ti tr nn sng hn, nm v t n nhang gim r rt
Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News
It is one of the studies conducted as part of the Semaglutide Treatment Effect for People (STEP) with obesity program